Literature DB >> 2797948

Persistent elastase/proteinase inhibitor imbalance during prolonged ventilation of infants with bronchopulmonary dysplasia: evidence for the role of nosocomial infections.

H Walti1, C Tordet, L Gerbaut, P Saugier, G Moriette, J P Relier.   

Abstract

Acute imbalance between elastase and alpha-1-proteinase inhibitor (alpha 1Pi) may contribute to the development of bronchopulmonary dysplasia (BPD). The question of whether such an imbalance persists in BPD infants still requiring mechanical ventilation after 4 wk of life has not been previously addressed. We studied 14 infants still on mechanical ventilation at 4 wk of age: nine had BPD and five did not. Weekly (4 to 9 wk) serum and bronchoalveolar lavage (BAL) specimens were taken. alpha 1Pi and alpha-2-macroglobulin were measured in serum and BAL by immunoturbidimetric assay. BAL elastase activity was measured by cleavage of a synthetic substrate and expressed as ng of porcine pancreatic elastase equivalent. Infants with BPD had higher levels of serum alpha 1Pi and alpha-2-macroglobulin than those without BPD. In contrast, the corresponding BAL levels were either similar or even decreased (alpha 1Pi). Moreover, there was a 3-fold increase in elastase-1Pi imbalance expressed as the BAL ng of porcine pancreatic elastase equivalent/2 alpha 1Pi ratio. The role of nosocomial infections was evident in a subgroup of 11 infected BAL aspirates in BPD infants. In such cases we found a 3-fold increase in the BAL ng of porcine pancreatic elastase equivalent/alpha 1Pi ratio as compared to 35 noninfected BAL in BPD infants. These data suggest a persistent alveolitis with imbalance between elastase and proteinase inhibitors in prolonged severe BPD. Such an imbalance is, in part, explained by a local destruction and/or inactivation of alpha 1Pi. Our results also emphasize the increase in proteolysis with nosocomial pneumonia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2797948     DOI: 10.1203/00006450-198910000-00013

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

1.  Inflammatory bronchopulmonary response of preterm infants with microbial colonisation of the airways at birth.

Authors:  P Groneck; B Goetze-Speer; C P Speer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

Review 2.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

3.  Inflammatory mediators and bronchopulmonary dysplasia.

Authors:  P Groneck; C P Speer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-07       Impact factor: 5.747

Review 4.  Chronic lung disease of prematurity: are we too cautious with steroids?

Authors:  M Silverman
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

5.  Elafin Treatment Rescues EGFR-Klf4 Signaling and Lung Cell Survival in Ventilated Newborn Mice.

Authors:  Miguel A Alejandre Alcazar; Mark Kaschwich; Robert Ertsey; Stefanie Preuss; Carlos Milla; Sana Mujahid; Juliet Masumi; Suleman Khan; Lucia M Mokres; Lu Tian; Jasmine Mohr; Dharmesh V Hirani; Marlene Rabinovitch; Richard D Bland
Journal:  Am J Respir Cell Mol Biol       Date:  2018-11       Impact factor: 6.914

6.  Relationship of proteinases and proteinase inhibitors with microbial presence in chronic lung disease of prematurity.

Authors:  Philip L Davies; O Brad Spiller; Michael L Beeton; Nicola C Maxwell; Eileen Remold-O'Donnell; Sailesh Kotecha
Journal:  Thorax       Date:  2010-03       Impact factor: 9.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.